Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2006
DOI: 10.3892/ijo.28.4.799
|View full text |Cite
|
Sign up to set email alerts
|

Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray

Abstract: Abstract. Distant metastasis is one of the crucial parameters determining the type of treatment and prognosis of patients. Previous studies discovered important factors involved in multiple steps of metastasis, the precise mechanisms of metastasis still remain to be clarified. To identify genes associated with this complicated biological feature of cancer, we analyzed expression profiles of 16 metastatic brain tumors derived from primary lung adenocarcinoma (ADC) using cDNA microarray representing 23,040 genes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
64
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 52 publications
(64 citation statements)
references
References 29 publications
0
64
0
Order By: Relevance
“…Until the results of ongoing studies attempting to correlate molecular biomarkers and gene products with clinical outcome in patients treated with neoadjuvant therapy for locally advanced NSCLC become applicable, it appears feasible to use pCR as a means of identifying patients who have a low enough risk of extracranial disease recurrence to benefit from vigilant surveillance or PCI. [30][31][32] The fact that 7 of 51 of patients experienced local-regional failure and an additional 6 of 51 had extracranial distant failure after pCR, however, suggests that pCR is neither a surrogate for complete remission nor an entirely accurate predictor of disease response to therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Until the results of ongoing studies attempting to correlate molecular biomarkers and gene products with clinical outcome in patients treated with neoadjuvant therapy for locally advanced NSCLC become applicable, it appears feasible to use pCR as a means of identifying patients who have a low enough risk of extracranial disease recurrence to benefit from vigilant surveillance or PCI. [30][31][32] The fact that 7 of 51 of patients experienced local-regional failure and an additional 6 of 51 had extracranial distant failure after pCR, however, suggests that pCR is neither a surrogate for complete remission nor an entirely accurate predictor of disease response to therapy.…”
Section: Discussionmentioning
confidence: 99%
“…To isolate such molecules, we have been analyzing genome-wide expression profiles of 101 lung cancers, using enriched populations of tumor cells prepared by laser microdissection (5)(6)(7)(8)(9). To verify the biological and clinicopathologic significance of the respective gene products, we have established a screening system by a combination of tumor tissue microarray analysis of clinical lung cancer materials with RNA interference (RNAi) technique .…”
Section: Introductionmentioning
confidence: 99%
“…One theory behind a specific tumors' proclivity to the brain is explained by Paget's seed and soil hypothesis, which suggests that for a seed (tumor cell) to take up in a soil (brain), it must adapt itself and make changes that will favor the soil [26,36]. In support of this idea, genes associated with breast cancer metastasis to b r a i nh a v eb e e nd i s c o v e r e da n de f f o r t sc o n t i n u e to identify new targets for lung cancer cell metastasis to the brain and for other cancers as well [37][38][39][40]. However, the question raised by the Figure 1.…”
Section: Primary Tumors Of Astrocytic Originmentioning
confidence: 99%